Pfizer Ltd shares surged over 10 percent after strong Q3FY26 results, with revenue up 20 percent and margins at 35 percent. Growth driven by brands like Prevenar 13, Eliquis, and Corex-DX.
Pfizer Ltd shares surged over 10 percent after strong Q3FY26 results, with revenue up 20 percent and margins at 35 percent. Growth driven by brands like Prevenar 13, Eliquis, and Corex-DX.